These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 2528120)

  • 1. Desmopressin (dDAVP): a powerful general hemostatic agent?
    Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).
    Kaufmann JE; Vischer UM
    J Thromb Haemost; 2003 Apr; 1(4):682-9. PubMed ID: 12871401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery.
    Kentro TB; Lottenberg R; Kitchens CS
    Am J Hematol; 1987 Feb; 24(2):215-9. PubMed ID: 3101493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.
    Mannucci PM
    Blood; 1997 Oct; 90(7):2515-21. PubMed ID: 9326215
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmopressin: an historical introduction.
    Mannucci PM
    Haemophilia; 2008 Jan; 14 Suppl 1():1-4. PubMed ID: 18173688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of desmopressin as a hemostatic agent: a concise review.
    Franchini M
    Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history.
    Sánchez-Luceros A; Meschengieser SS; Turdó K; Arizó A; Woods AI; Casais P; Blanco AN; Kempfer AC; Lazzari MA
    Thromb Res; 2007; 120(3):387-90. PubMed ID: 17056101
    [No Abstract]   [Full Text] [Related]  

  • 11. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
    Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
    Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR; Tuller J; Johnson JA
    Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin, hemostasis, and vascular surgery.
    Clagett GP
    Semin Vasc Surg; 1996 Dec; 9(4):340-6. PubMed ID: 8958610
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL; Shi Q; Montgomery RR
    Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variant type von Willebrand disease with defective binding to factor VIII].
    Shima M
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylaxis in von Willebrand disease.
    Franchini M; Targher G; Lippi G
    Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.